Store
Biopharmaceutical Contract Manufacturing Organization (BCMO) Market, 2022
Publication Date: August 2, 2022
Tags: Pharmaceuticals
Pages: 180
SKU: 22-033
Enhance your understanding of the biopharmaceutical contract manufacturing market with Kalorama Information’s detailed and data-rich report, Biopharmaceutical Contract Manufacturing Organization (BCMO) Market, 2022. Stay ahead of industry trends and make informed decisions with the insights provided in this comprehensive market analysis.
Key Highlights:
- Sales Estimates and Forecasts: Detailed sales estimates are provided for the period from 2016 to 2021, with forecasts extending through 2026. All figures are expressed in current dollars, giving you a clear view of market trends.
- Third-Party Manufacturing Analysis: Examine the third-party manufacturing landscape for both potential and commercialized prescription drug products worldwide. Potential drug products are those in clinical (Phase I – Phase III) testing, requiring smaller quantities for evaluation, while commercialized drugs have received regulatory approval and are available in mass markets.
- Regulatory Landscape: Understand the regulatory approvals across different regions, such as the EU and the US, and their impact on the BCMO market.
Market Information Included:
- BCMO Market Trends: Sales estimates from 2016-2021 and forecasts from 2022-2026.
- Top BCMO Companies: Profiles of leading companies in the BCMO sector.
- Regional Markets: In-depth analysis of BCMO markets by region, including the U.S., Western Europe, Eastern Europe, China, India, Other Asia, Latin America, and Rest of World.
- Market Segments: Breakdown of the BCMO market by segment, including Clinical Manufacturing and Commercial Manufacturing.
Benefits of This Report:
- Strategic Insights: Gain a comprehensive understanding of the global BCMO market to inform strategic decisions.
- Competitive Analysis: Learn about the top players in the industry and their market positions.
- Market Opportunities: Identify growth opportunities and potential challenges in different regional markets.
- In-Depth Data: Access detailed market data and forecasts to support business planning and investment decisions.
Table: Total Global BCMO Market, 2016–2026, by Service (in billions $)
| Year | Clinical Manufacturing | Commercial Manufacturing | Total |
| 2016 | $XX Billion | $XX Billion | $XX Billion |
| 2017 | $XX Billion | $XX Billion | $XX Billion |
| 2018 | $XX Billion | $XX Billion | $XX Billion |
| 2019 | $XX Billion | $XX Billion | $XX Billion |
| 2020 | $XX Billion | $XX Billion | $XX Billion |
| 2021 | $XX Billion | $XX Billion | $XX Billion |
| 2022 | $XX Billion | $XX Billion | $XX Billion |
| 2023 | $XX Billion | $XX Billion | $XX Billion |
| 2024 | $XX Billion | $XX Billion | $XX Billion |
| 2025 | $XX Billion | $XX Billion | $XX Billion |
| 2026 | $XX Billion | $XX Billion | $XX Billion |
| CAGR 2016 – 2021 | XX% | XX% | XX% |
| CAGR 2016 – 2026 | XX% | XX% | XX% |
| CAGR 2021 – 2026 | XX% | XX% | XX% |
Source: Kalorama Information
For further details and to purchase directly, please contact us.
Table of Contents
Chapter 1: Executive Summary
The Biopharmaceutical Contract Manufacturing (BCMO) Industry
Scope and Methodology
The BCMO Services Market
- Figure 1-1: Total Global BCMO Market Growth in $ Billions, 2016 – 2026, by Service
Cell and Gene Therapy
Chapter 2: Overview
Introduction
Factors Contributing to the Growth of Contract Manufacturing
Biotechnology
Biosimilars
Cell and Gene Therapies
Chapter 3: The Contract Manufacturing Industry
Contract Manufacturing Organizations
The Role of BCMOs
Services Offered by BCMOs
The Rise of CDMOs
Embedded vs. Stand Alone CMOs
Cell and Gene Therapy CMOs
Advancing Technology
Dearth of Intellectual Capital
cGMP Compliance
Quality by Design
SWOT Analysis
Strengths
Opportunities
Weaknesses
Threats
Chapter 4: Total Global BCMO Market
Overview
Global Market Forecasts
- Table 4-1: Total Global BCMO Market in $ Billions, 2016 – 2026, by Service
- Figure 4-1: Total Global BCMO Market Growth in $ Billions, 2016 – 2026, by Service
- Table 4-2: Total Global BCMO Market in $ Billions, Biotech Segment, 2016 – 2026, by Service
- Figure 4-2: Total Global BCMO Market Growth in $ Billions, Biotech Segment, 2016 – 2026, by Service
Regional Market Overview
- Table 4-3: Total Global BCMO Market in $ Billions, 2016 – 2026, by Major Region
- Figure 4-3: Total Global BCMO Market Growth in $Billions, 2016 – 2026, by Major Region
- Table 4-4: Total Global BCMO Market in $ Billions, Biotech Segment, 2016 – 2026, by Major Region
- Figure 4-4: Total Global BCMO Market Growth in $Billions, Biotech Segment, 2016 – 2026, by Major Region
Key Players and Global Market Share
- Figure 4-5: Major Players in the Global BCMO Market, by Share, 2021
- Table 4-5: Estimated BCMO Revenues of Major Players in the Global BCMO Market in $Millions, 2021
Cell and Gene Therapy
- Table 4-6: Cell and Gene Therapy BCMO (in billions of dollars), 2021 and 2026
Future Market Trends
The Future of Pharma and BioPharma Manufacturing
The Future of Contract Manufacturing
Chapter 5: The BCMO Market by Region
Introduction
Established Markets
Emerging Markets
The Global BCMO Market by Region
- Table 5-1: Total Global BCMO Market in $ Billions, 2016 – 2026, Segmented by Region
- Figure 5-1: Total Regional BCMO Market Growth in $Billions, 2016 – 2026
- Table 5-2: Total Global BCMO Market in $ Billions, Biotech Segment, 2016 – 2026, by Region
- Figure 5-2: Total Regional BCMO Market Growth in $Billions, Biotech Segment, 2016 – 2026
The U.S. BCMO Market
Overview
Market Forecasts
- Table 5-3: Total U.S. BCMO Market in $Billions, 2016 – 2026, by Service
- Figure 5-3: Total U.S. BCMO Market Growth in $Billions, 2016 – 2026, by Service
- Table 5-4: Total U.S. BCMO Market in $Billions, Biotech Segment, 2016 – 2026, by Service
- Figure 5-4: Total U.S. BCMO Market Growth in $Billions, Biotech Segment, 2016 – 2026, by Service
The Western European BCMO Market
Overview
Market Forecasts
- Table 5-5: Total Western Europe BCMO Market in $Billions, 2016 – 2026, by Service
- Figure 5-5: Total Western Europe BCMO Market Growth in $Billions, 2016 – 2026, by Service
- Table 5-6: Total Western Europe BCMO Market in $Billions, Biotech Segment, 2016 – 2026, by Service
- Figure 5-6: Total Western Europe BCMO Market Growth in $Billions, Biotech Segment, 2016 – 2026, by Service
The Eastern European BCMO Market
Overview
Market Forecasts
- Table 5-7: Total Eastern Europe BCMO Market in $Billions, 2016 – 2026, by Service
- Figure 5-7: Total Eastern European BCMO Market Growth in $ Billions, 2016 – 2026, by Service
- Table 5-8: Total Eastern Europe BCMO Market in $Billions, Biotech Segment 2016 – 2026, by Service
- Figure 5-8: Total Eastern European BCMO Market Growth in $ Billions, Biotech Segment, 2016 – 2026, by Service
The Chinese BCMO Market
Overview
Market Forecasts
- Table 5-9: Total China BCMO Market in $ Billions, 2016 – 2026, by Service
- Figure 5-9: Total China BCMO Market Growth in $ Billions, 2016 – 2026, by Service
- Table 5-10: Total China BCMO Market in $ Billions, Biotech Segment, 2016 – 2026, by Service
- Figure 5-10: Total China BCMO Market Growth in $ Billions, Biotech Segment, 2016 – 2026, by Service
The Indian BCMO Market
Overview
Market Forecasts
- Table 5-11: Total India BCMO Market in $ Billions, 2016 – 2026, by Service
- Figure 5-11: Total India BCMO Market Growth in $ Billions, 2016 – 2026, by Service
- Table 5-12: Total India BCMO Market in $ Billions, Biotech Segment, 2016 – 2026, by Service
- Figure 5-12: Total India BCMO Market Growth in $ Billions, Biotech Segment, 2016 – 2026, by Service
The Rest of World BCMO Market
Overview
Asia
Latin America
Other Countries
Market Forecasts
- Table 5-13: Total ROW BCMO Market in $ Billions, 2016 – 2026, by Service
- Figure 5-13: Total ROW BCMO Market Growth in $ Billions, 2016 – 2026, by Service
- Table 5-14: Total ROW BCMO Market in $ Billions, Biotech Segment, 2016 – 2026, by Service
- Figure 5-14: Total ROW BCMO Market Growth in $ Billions, Biotech Segment, 2016 – 2026, by Service
Chapter 6: Pharmaceutical & Biotech Company Profiles
3p Biopharmaceuticals
3sbio Group/Shenyang Sunshine Pharmaceuticals Co., Ltd.
Abbvie
Aenova
Agc Biologics
Ajinomoto Bio-Pharma Services
Anemocyte
Asahi Glass Co.
Aurobindo
Avara Pharmaceutical Services
Bachem
Baxter Biopharma Solutions
Boehringer Ingelheim Bioxcellence
Bora Pharmaceuticals
Catalent
Cellipoint Bioservices
Celonic Ag
Charles River Labs/Cognate Bioservices
Cordenpharma
Curia
Cytiva/Danaher
Cytovance Biologics
Dr. Reddy’s Laboratories
Evonik
Excellgene
Fareva
Fresenius Kabi Product Partnering
Fujifilm Diosynth Biotechnologies
Grifols
Idifarma
Jubilant Biosys
Kemwell Biopharma
Lfb Sa
Lonza
Luinabio
Matica Biotechnology/Cha Biotech
Menarini Biotech
Novasep
Lubrizol Life Science Health
Millipore Sigma/Bioreliance/Merck Kgaa
Minaris Regenerative Medicine
Novartis
Oxford Biomedica
Patheon/Thermo Fisher Scientific
Pci Pharma Services
Pfizer Centreone
Piramal Pharma Solutions
Pluristyx
Porton Biologics
Recipharm
Rentschler Biotechnologie Gmbh
Resilience
Rovi Contract Manufacturing
Samsung Biologics
Siegfried Ag
Sl Pharma Labs
Stelis Biopharma/Strides Shashun Ltd.
Stgen Bio
Symbiosis Pharmaceutical Services
Syngene International
Takara Bio
Takeda
Tcg Lifesciences
Teuto
The Center For Breakthrough Medicines
Tianjin Pharmaceutical
Upm Pharmaceuticals
Vetter Pharma International Gmbh
Vibalogics
Woodfield Pharmaceutical
Wuxi Apptec
Yposkesi


